Targeting the Optimal Antibody Strategy for a Noninvasive Diagnosis of Phospholipase A2 Receptor-Associated Membranous Nephropathy: Is Serology Alone Sufficient?
作者信息
Bobart Shane A, Fervenza Fernando C
机构信息
Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville, Florida.
Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota.
出版信息
Clin J Am Soc Nephrol. 2025 May 1;20(5):598-600. doi: 10.2215/CJN.0000000710. Epub 2025 Apr 4.
PMID:40338635
Abstract
摘要
相似文献
[1]
[2]
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
Clin J Am Soc Nephrol. 2021-12
[3]
[4]
[5]
[6]
[7]
[8]
[9]
本文引用的文献
[1]
Noninvasive Diagnostic Strategies for Membranous Nephropathy in the Nephrotic Syndrome Study Network.
Clin J Am Soc Nephrol. 2025-5-1
[2]
Membranous nephropathy-diagnosis and identification of target antigens.
Nephrol Dial Transplant. 2024-3-27
[3]
[4]
Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy: A Validation Study.
Clin J Am Soc Nephrol. 2021-12
[5]
[6]
[7]
[8]
[9]
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy.
N Engl J Med. 2009-7-2